Health
Study links metformin to slowed cognitive decline – Australian Hospital + Healthcare Bulletin
A study of older Australians with type 2 diabetes revealed that taking metformin resulted in slower cognitive decline with lower dementia rates than those who d…
Used by millions of people across the globe to optimise blood glucose levels, metformin is regarded as the first-line treatment for most cases of type 2 diabetes.
A six-year study of older Australians with type 2 diabetes has revealed that those taking metformin experienced slower cognitive decline with lower dementia rates than those who did not use the medication.
Led by researchers at the Garvan Institute of Medical Research and the Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney, the …
-
Noosa News13 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
Noosa News19 hours agoChilling new details emerge in terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General22 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
General24 hours agoRed tape on chopping block in bid to build homes faster